C R Conti. Show Affiliations »
Abstract
Mesh: See more » ContraindicationsFemaleHumansMenstruation/drug effectsMenstruation/physiologyMiddle AgedMyocardial Infarction/drug therapyThrombolytic TherapyUrokinase-Type Plasminogen Activator/therapeutic use
Substances: See more » Urokinase-Type Plasminogen Activator
Year: 1992 PMID: 1395195 DOI: 10.1002/clc.4960150902
Source DB: PubMed Journal: Clin Cardiol ISSN: 0160-9289 Impact factor: 2.882